On the Establishment of Generic Reference Formulations in China's National Essential Drug List

Zhao Fei, Zhao Zinan, Xue Wei, Qi Wenyuan, Yao Huiqing, Wang Juan, Xu Xiaoyu, Liu Xiaohui, Jin Pengfei, Ji Liwei, Zhang Yatong, Li Kexin, Hu Xin

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (9) : 972-978.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (9) : 972-978. DOI: 10.16153/j.1002-7777.2021.09.002
Supervision Administration

On the Establishment of Generic Reference Formulations in China's National Essential Drug List

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(9): 972-978 https://doi.org/10.16153/j.1002-7777.2021.09.002

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/